|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 49, 1621-1639, August 2008
Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols*
* Department of Chemistry, Emory University, Atlanta, GA 30322 * The work from our laboratories on naturally occurring sphingolipids cited in this review was supported by National Institutes of Health Grants GM-076217 and GM-069338 (Lipid Maps Consortium), and work involving sphingolipid analogs was supported by funding from the National Cancer Institute (Grant CA-87525). Published, JLR Papers in Press, May 21, 2008.
2 To whom correspondence should be addressed. e-mail: al.merrill{at}biology.gatech.edu
"Sphingosin" was first described by J. L. W. Thudichum in 1884 and structurally characterized as 2S,3R,4E-2-aminooctadec-4-ene-1,3-diol in 1947 by Herb Carter, who also proposed the designation of "lipides derived from sphingosine as sphingolipides." This category of amino alcohols is now known to encompass hundreds of compounds that are referred to as sphingoid bases and sphingoid base-like compounds, which vary in chain length, number, position, and stereochemistry of double bonds, hydroxyl groups, and other functionalities. Some have especially intriguing features, such as the tail-to-tail combination of two sphingoid bases in the
Supplementary key words sphinganine phytosphingosine fumonisin myriocin long-chain base anti-tumor anti-fungal Abbreviations: SPT, serine palmitoyltransferase
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||